Julia A. Gaebler

Julia A. Gaebler has a varied work experience in the healthcare industry. Julia is currently working at Cytel as the VP and GM of Market Access. Prior to this, they served as the Chief Business Officer at Lucy Therapeutics from September 2022 to July 2023. Julia also worked at Milestone Pharmaceuticals, Inc. as the VP of Commercial Strategy & Portfolio Planning from March 2021 to September 2022.

In addition, Julia has worked at various other companies in different roles. Julia was a Partner at Health Advances, a global strategy consulting firm specializing in the healthcare industry, from December 2017 to March 2021. Before that, they served as a Vice President at Health Advances from September 2014 to December 2017.

Julia has also worked at Biogen Idec as a Senior Director of Global Medical Affairs, as well as a Director of Commercial Operations in Global Market Access from April 2011 to August 2014. Prior to that, they worked at Amylin Pharmaceuticals and RAND Corporation in various roles related to medical affairs, pricing, and policy research. Their early career includes a position at Roche Pharmaceuticals as a Manager in Research and Development for Global Pricing and Pharmacoeconomics from 1995 to 1999.

Overall, Julia Gaebler has a wealth of experience in various roles related to market access, commercial strategy, and healthcare consulting.

Julia A. Gaebler has a strong educational background with degrees from top universities. Julia completed their PhD in Health Policy with a concentration in Decision Sciences at Harvard University from 1999 to 2004. Prior to that, they pursued a Master of Arts degree in International Economics & European Studies at the Johns Hopkins School of Advanced International Studies (SAIS) from 1993 to 1995. Julia A. Gaebler obtained their Bachelor of Arts in European Intellectual History from the University of Pennsylvania, where they studied from 1987 to 1991. Additionally, they attended The Sidwell Friends School, although no specific degree or field of study was provided for this period.